Loading...
XJPX
3151
Market cap466mUSD
Jul 10, Last price  
1,560.00JPY
1D
-0.32%
1Q
3.65%
Jan 2017
57.58%
IPO
196.58%
Name

Vital Ksk Holdings Inc

Chart & Performance

D1W1MN
XJPX:3151 chart
P/E
10.25
P/S
0.12
EPS
152.18
Div Yield, %
3.71%
Shrs. gr., 5y
-2.58%
Rev. gr., 5y
2.60%
Revenues
610.50b
+1.69%
534,698,000,000532,053,000,000541,636,000,000547,590,000,000564,645,000,000548,007,000,000620,978,000,000581,117,000,000565,587,000,000559,718,000,000562,529,000,000537,058,000,000577,249,000,000579,772,000,000587,481,000,000600,370,000,000610,497,000,000
Net income
7.36b
+0.73%
2,786,000,000-1,067,000,0003,154,000,0003,908,000,0004,235,000,0004,527,000,0006,556,000,0004,778,000,0004,467,000,0005,084,000,0004,642,000,0001,171,000,0004,770,000,0004,831,000,0005,843,000,0007,309,000,0007,362,000,000
CFO
4.83b
P
3,005,000,0005,226,000,00012,863,000,00010,123,000,000-10,409,000,0009,515,000,000-2,350,000,0001,116,000,00016,783,000,00018,229,000,000-8,323,000,000-1,389,000,0007,487,000,000-3,001,000,00023,570,000,000-8,024,000,0004,833,000,000
Dividend
Sep 29, 202635 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Vital KSK Holdings, Inc. is a Japanese entity primarily involved in the wholesale distribution of pharmaceutical products. Its diverse wholesale operations also cover veterinary medications, agricultural chemicals and supplies, and various types of medical and nursing care equipment. Beyond its core distribution activities, the company manages a range of services including operating pharmacies, providing nursing care, transportation, insurance agency services, real estate management, and parking facilities. It also runs a mail-order business focused on health-related products and offers pharmacy dispensing services. Furthermore, Vital KSK Holdings provides medical management consulting and manufactures over-the-counter (OTC) drugs. The company was established in 2009 and maintains its headquarters in Tokyo, Japan.
IPO date
Apr 01, 2009
Employees
3,719
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT